The FDA Updates Templates for Serology EUA Requests

The U.S. Food and Drug Administration (FDA) updated the templates for laboratories and commercial manufacturers to help facilitate submission of Emergency Use Authorization (EUA) requests for serology tests.The updates clarify FDA’s previous recommendations for demonstrating clinical performance and presenting validation data, and provide new recommendations for validation of point-of-care tests.

Questions?

If you have questions, email COVID19Dx@fda.hhs.gov.

BioFlorida recognizes the need to share important information involving COVID-19 with our members and the Community.

OurCOVID-19 Resource Centeris updated regularly with the latest data, legislation and programs for businesses and research in the state; news about diagnostics, vaccines and therapeutics; and ways to contribute to the fight against COVID-19.